Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Amphion Innovations (AMP)

  Print      Mail a friend       Annual reports

Monday 25 October, 2010

Amphion Innovations

Partner Update

RNS Number : 9104U
Amphion Innovations PLC
25 October 2010



EU certification for colour X ray technology will see the end of liquid flight ban

Major milestone for Amphion Partner Company, Kromek


London and New York, 25 October 2010 - Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, today announces that its Partner Company, Kromek, which specialises in the development of disruptive technology solutions for a range of commercial markets including airport and border security, has received official European Union (EU) certification to provide colour x-ray liquid detection systems to all European airports.


By April 2011, liquid items bought in transit (i.e. duty free purchases) will be allowed on board, providing the appropriate security measures, such as screening, are in place at the airports concerned. The results of the European Civil Aviation Conference (ECAC) led trials establish that the technology is ready to allow the 2011 deadline to be met by the airports.  By April 2013, the ban will be lifted completely, allowing the carriage of liquids on flights across Europe.


Kromek's Bottle Scanner has qualified as a Category B device that has achieved Type 1 and Type 2 100% capability and has been officially tested, verified and authorised by ECAC.  As of now, all EU airports are free to buy and implement Kromek's Bottle Scanner product, opening the company to the multi million dollar airport security market. 


The move marks a breakthrough in airport security.  As the threat from liquid threat has become greater, airport security officials are seeking appropriate technology to mitigate this threat.  For the first time, airports can purchase tested, approved, and secure technology that will allow authorities to relax the ban on liquid on flights.


Dr. Arnab Basu, CEO of Kromek, said, "It's a significant milestone for Kromek as the approved listing is vindication that colour x-ray detection has been proven.  The next generation of X-ray technology has arrived, with a market ready machine that can detect liquid threat.


"The threat from Liquid, Aerosol and Gel (LAG) based explosives became apparent in August 2006 following discovery of a plot to use such devices aboard multiple transatlantic flights. Although Kromek had not set out to produce such equipment we were quick to realise with our capabilities we had the versatility to produce a solution for this market need.


Kromek's verified and approved solution effectively guards against such a possibility. It is a major step forward in the fight against global terrorism where liquid is increasingly becoming a common tool for terrorist use."


Kromek's revolutionary technology signals a new era in colour x-ray detection, and a market-changing development in aviation security. The company is introducing to the sector a pioneering form of detection, which has been likened to the advent of colour TV, from black and white, in terms of significance and market potential.


Richard Morgan, CEO of Amphion and Chairman of Kromek, said, "This approval by the ECAC is a major milestone for Kromek.  Kromek's proven technology meets a previously unmet need in airport security. Kromek's Bottle Scanner should make a major contribution to a more efficient security system within the European markets."


Dr. Basu concluded, "The next year and beyond is extremely exciting for us. Kromek will continue to see strong growth over the coming years as our innovative solutions to many previously intractable problems captures the imagination.  Our groundbreaking technology not only provides products to the airline security market but has the opportunity for development into a range of products for many highly lucrative markets such as medical and industrial fields."


For further information please contact

Amphion Innovations plc
Charlie Morgan
+1 (212) 210 6224

Cardew Group
Tim Robertson/ James Milton
+44 20 7930 0777

Charles Stanley (Nominated Adviser)
Mark Taylor
+44 20 7149 6000


About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK.   Amphion has significant shareholding in 10 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.

On the web:

About Kromek

Kromek was spun out of Durham University's physics department and specialises in the development of disruptive technology solutions for a broad range of commercial markets. It is currently pioneering digital colour imaging for x-rays and advanced 3D imaging for the medical, security, industrial inspection and defence markets.  The company has successfully pioneered a revolutionary 3D x-ray technology, which has huge commercial benefits for a range of sectors, especially the airline security industry, where it is uniquely placed to fulfil an increasing, necessary worldwide demand for liquid explosive detection at airports.

On the web:




This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t